Lindbrook Capital’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
Other funds holding INVA
SCM
SFM
Lindbrook Capital's INVA Position: Q1 2025 in Review
Lindbrook Capital increased its Innoviva (INVA) stake by 27% in Q1 2025, buying an estimated $1.22K and bringing the position to 320 shares worth $5.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1898.
Lindbrook Capital first reported a position in INVA in Q2 2022 and has held it in 12 quarters since. The position peaked at $13K in Q2 2022. 246 funds tracked by Wall St. Rank hold INVA as of Q1 2025.
- Lindbrook Capital held 320 shares of Innoviva worth $5.8K as of Q1 2025.
- Lindbrook Capital bought 68 Innoviva shares in Q1 2025, an estimated $1.22K.
- Innoviva made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1898 holding.
- Lindbrook Capital first reported a position in Innoviva in Q2 2022 and has held it in 12 quarters since.
- Lindbrook Capital's Innoviva position peaked at $13K in Q2 2022.
- 246 funds tracked by Wall St. Rank held Innoviva as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.